Chronic effects of dehydroepiandrosterone on rat adipose tissue metabolism

Metabolism: Clinical and Experimental

Volumn 52, Issue 3, 2003, Pages 264-272

  Mauriège, Pascale ^a,b,c   Martel, C ^a,b,c   Langin, D ^a,b,c   Lacaille, M ^a,b,c   Despres J P ^a,b,c   Belanger A ^a,b,c   Labrie, F ^a,b,c   Deshaies, Y ^a,b,c  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ANDROSTENEDIOL; ANDROSTENEDIONE; ANDROSTERONE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; CHOLESTEROL; CYCLIC AMP PHOSPHODIESTERASE; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; INSULIN; LIPID; LIPOPROTEIN LIPASE; PRASTERONE; PROTEIN; SEX HORMONE; TESTOSTERONE; TRIACYLGLYCEROL LIPASE;

ADIPOSE TISSUE; ADIPOSE TISSUE CELL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY FAT; BODY WEIGHT; CELL METABOLISM; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HEALTH STATUS; HORMONE BLOOD LEVEL; LIPID METABOLISM; LIPID STORAGE; LONG TERM CARE; MUSCLE MASS; NONHUMAN; OBESITY; OVARIECTOMY; OVARY; PREDICTION; PRIORITY JOURNAL; RAT; RETROPERITONEUM; STEROID BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TISSUE METABOLISM;

EID: 0037356086     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2003.50043     Document Type: Article

References (45)

1. Nestler JE, Clore JN, Blackard WG: Dehydroepiandrosterone: The "missing link" between hyperinsulinemia and atherosclerosis? FASEB J 6:3073-3075, 1992
2. Berdanier CD, Parente JA, McIntosh MK: Is dehydroepiandrosterone an antiobesity agent? FASEB J 7:414-419, 1993
3. Clore JN: Dehydroepiandrosterone and body fat. Obes Res 3:613S-616S, 1995 (suppl 4)
4. Cleary MP: The antiobesity effects of dehydroepiandrosterone in rats. Proc Soc Exp Biol Med 196:8-16, 1991
5. Taniguchi S, Yanase T, Haji M, et al: The antiobesity effect of dehydroepiandrosterone in castrated or noncastrated obese Zucker male rats. Obes Res 3:639S-643S, 1995 (suppl 5)
6. Han D-H, Hansen PA, Chen MM, et al: DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats. J Gerontol Biol Sci 53:B19-B24, 1998
7. Tagliaferro AR, Ronan AM, Payne J, et al: Increased lipolysis to β-adrenergic stimulation after dehydroepiandrosterone treatment in rats. Am J Physiol 268:R1374-R1380, 1995
8. Lea-Currie YR, Wu SM, McIntosh MK: Effects of acute administration of dehydroepiandrosterone-sulfate on adipose tissue mass and cellularity in male rats. Int J Obes Relat Metab Dis 21:147-154, 1997
9. Lea-Currie YR, Wen P, McIntosh MK: Dehydroepiandrosterone-sulfate (DHEAS) reduces adipocyte hyperplasia associated with feeding rats a high fat diet. Int J Obes Relat Metab Dis 21:1058-1064, 1997
10. Arner P, Eckel RH: Adipose tissue as a storage organ, in Bray GA, Bouchard C, James WPT (eds): Handbook of Obesity. New York, NY, Dekker, 1998, pp 379-395
11. Langin D, Holm C, Lafontan M: Adipocyte hormone-sensitive lipase: A major regulator of lipid metabolism. Proc Nutr Soc 55:93-109, 1996
12. Lafontan M, Berlan M: Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 34:1057-1091, 1993
13. m cAMP-phosphodiesterase in rat fat cells by phosphorylation. Proc Natl Acad Sci USA 7:533-537, 1990
14. Mortola JF, Yen SSC: The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 71:696-704, 1990
15. Morales AJ, Nolan JJ, Nelson JC, et al: Effects of replacement dose of dehydroepiandrosterone in men and women with advancing age. J Clin Endocrinol Metab 78: 1360-1367, 1994
16. Diamond P, Cusan L, Gomez JL, et al: Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 150:S43-S50, 1996 (suppl)
17. Labrie F, Diamond P, Cusan L, et al: Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 82:3498-3505, 1997
18. Labrie C, Flamand M, Bélanger A, et al: High bioavailability of dehydroepiandrosterone administered percutaneously in the rat. J Endocrinol 150:S107-S118, 1996 (suppl)
19. Martel C, Sourla A, Pelletier G, et al: Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat. J Endocrinol 157:433-442, 1997
20. Ke HZ, Paralkar VM, Grasser WA, et al: Effects of CP-336,156, a new nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus, and body composition in rat models. Endocrinology 139:2068-2076, 1998
21. Bérubé R, Malenfant J, Gauvin D, et al: Quantitation of androgenic and estrogenic steroids in rat and monkey serum using gas chromatography and negative chemical ionization mass spectrometry. Proceedings of the 48th ASMS Conference on Mass Spectrometry and Allied Topics, Long Beach, CA, 2000
22. Savard R, Deshaies Y, Després JP, et al: Lipogenesis and lipoprotein lipase in human adipose tissue. Reproducibility of measurements and relationships with fat cell size. Can J Physiol Pharmacol 62:1448-1452, 1984
23. Solomon SS: Phosphodiesterase activity of rat and human adipose tissue. J Lab Clin Med 79:598-610, 1972
24. DeMazancourt P, Giudicelli Y: Guanine nucleotides and adenosine "Ri"-site analogues stimulate the membrane-bound low Km cyclic AMP phosphodiesterase of rat adipocytes. FEBS Lett 173:385-388, 1984
25. Lowry OH, Rosenbrough NJ, Farr A, et al: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
26. Fredriksson G, Stralfors P, Nilsson NO, et al: Hormone-sensitive lipase from rat. Methods Enzymol 71:363-646, 1981
27. Frayn KN, Langin D, Holm C, et al: Hormone-sensitive lipase: Quantitation of enzyme activity and mRNA level in small biopsies of human adipose tissue. Clin Chim Acta 216:183-189, 1993
28. Mauriège P, Imbeault P, Langin D, et al: Regional and gender variations in adipose tissue lipolysis in response to weight loss. J Lipid Res 40:1559-1571, 1999
29. Mauriège P, Atgié C, Simard PM, et al: Major lipolytic defects in white adipocytes from different depots of a new model of type II diabetes: The obese SHR/N-cp rat. Obes Res 3:630s, 1995 (abstr)
30. Tavernier G, Galitzky J, Valet P, et al: Molecular mechanisms underlying regional variations of catecholamine-induced lipolysis in rat adipocytes. Am J Physiol 268:E1135-E1142, 1995
31. 2-receptor subtypes. Eur J Biochem 146:339-346, 1985
32. Mauriège P, De Pergola G, Berlam M, et al: Human fat cell beta-adrenergic receptors: Beta-agonist dependent lipolytic responses and characterization of beta-adrenergic binding sites on human fat cell membranes with highly selective beta1-antagonists. J Lipid Res 29:587-601, 1988
33. 3-adrenoceptors in intact brown adipocytes. Br J Pharmacol 114:275-282, 1995
34. Rebuffé-Scrive M: Sex steroid hormones and adipose tissue metabolism in ovariectomized rats. Acta Physiol Scand 129:471-477, 1987
35. Deshaies Y, Dagneault A, Richard D: Tissue- and gender-specific modulation of lipoprotein lipase in intact and gonadectomised rats treated with dl-fenfluramine. Int J Obes 18:405-411, 1994
36. m cyclic AMP phosphodiesterase of rat adipocytes from different sites: Influence of ovariectomy. Biochim Biophys Acta 1136:99-104, 1992
37. De Pergola G, Holmang A, Svedberg J, et al: Testosterone treatment of ovariectomized rats: Effects on lipolysis regulation in adipocytes. Acta Endocrinol 123:61-66, 1990
38. Simard PM, Atgié C, Mauriège P, et al: Comparison of the lipolytic effects of norepinephrine and BRL37344 in rat brown and white adipocytes. Obes Res 2:424-431, 1994
39. Xu X, De Pergola G, Eriksson PS, et al: Post receptors events involved in the up-regulation of beta-adrenergic receptor mediated lipolysis by testosterone in rat white adipocytes. Endocrinology 132:1651-1657, 1993
40. Labrie F: At the cutting edge. Intracrinology. Mol Cell Endocrinol 78:C113-C118, 1991
41. Mohan PF, Ihnen JS, Levin BE, et al: Effects of dehydroepiandrosterone treatment in rats with diet-induced obesity. J Nutr 120:1103-1114, 1990
42. Muller S, Cleary MP: Glucose metabolism in isolated adipocytes from lean and obese Zucker rats following treatment with dehydroepiandrosterone. Metabolism 34:278-284, 1985
43. Coleman DL, Schwizer RW, Leiter EH: Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes/obesity mutants and in aged normal mice. Diabetes 33:26-32, 1984
44. Kurzman ID, Panciera DL, Miller JB, et al: The effect of dehydroepiandrosterone combined with a low-fat diet in spontaneously obese dogs: A clinical trial. Obes Res 6:20-28, 1998
45. Després JP: The insulin-resistance-dyslipidemic syndrome of visceral obesity: Effect on patients' risk. Obes Res 6:8S-18S, 1998 (suppl 1)